Using AI to make a big impact for emerging and mid-sized biopharma companies

How healthcare professionals prefer to engage with pharma companies has been changing for some time, and COVID’s digital transformation of society has dramatically accelerated this.

This pharmaphorum webinar – in association with Axtria – will take place on Wednesday 14th April from 16:00-17:00 BST / 11:00-12:00 EDT and look at customer engagement and the future of pharma’s field force.

Previously viewed as a ‘nice to have’ for the pharma industry, virtual clinical trials were already moving from a theoretical to a practical proposition before COVID-19 accelerated their transition.

This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), will take place on Thursday 25th March 15:30 GMT / 16:30 CET and look at where virtual trials fit into the next generation of commercial clinical research.

The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical research at a time of immense pressure and stress on personnel and resources.

This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), will take place on Thursday 25th February 13:00 GMT / 14:00 CET and discuss the UK’s approach to delivering research during the COVID-19 pandemic.

Involving patients in clinical trial design can hugely benefit pharmaceutical research's sustainability.

This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), takes place on Wednesday 16th December, 11:00 GMT / 12:00 CET and will look at how to navigate the compliance pathway to increase patient engagement with clinical trials.

The five new NIHR national Patient Recruitment Centres (PRCs) are set to shape the future of commercial clinical trials in the UK by offering new ways to conduct late-phase, large-scale research projects.

This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), takes place on Thursday 12th November, 14:00 GMT / 15:00 CET and will introduce the new NIHR national Patient Recruitment Centres and look at how the PRCs will take a patient-centric approach to pharmaceutical research.

With exclusive surveys of the continuing medical education (CME) needs of haematologists/oncologists (haem/oncs), this webinar will look at where physicians are going for their learning needs and what effect the COVID-19 pandemic continues to have.

The Behavioural insights into haem/onc clinical decision-making webinar, in association with Medscape, will take place on Thursday 3rd September from 13:00-14:00 (BST)/14:00-15:00 (CEST).

This webinar will look at how pharma can use modular content in its multichannel and omnichannel strategies.

Presented in association with Viseven, it will also include ways to improve, and speed up, the content supply chain and hear how Novo Nordisk designs and executes customer engagement journeys

COVID-19 has brought many changes to the pharmaceutical industry, among them a need to change how pharma companies engage with HCPs and transform their approach to digital channels.

This webinar, held in association with Veeva, will present some exclusive market observations from before and during the COVID crisis and explain how pharmaceutical companies can increase their digital IQ and accelerate the move to digital.

As use of real-world evidence increases there is an opportunity to improve the patient experience.

In addition to key steps forward with the establishment of Health Data Research UK and NHSX, information governance will be key, as is alignment to UK and EU regulations such as the July 2019 DHSC Framework for the Value of NHS Research and GDPR.

Insights on the impact of COVID-19 for pharma and biotech companies and considerations for a post-coronavirus new normal in life sciences and healthcare.

It will also discuss the UK response to the emergency, clinical trials and how digital health has met the COVID-19 challenge for healthcare professionals, patients and industry.

COVID-19 is making digital transformation even more pressing for pharmaceutical companies.

Amid the coronavirus pandemic digital health offers many ways to develop public utility projects and enhance healthcare communications.

Overview

This April webinar is part of IQVIA’s monthly updates on the impact of COVID-19 and its implications for the healthcare ecosystem.

In the global effort to proactively fight COVID-19, the webinar series has been designed to:
•Provide some areas which pharma and biotech companies may wish to consider around the COVID-19 outbreak, in order to help guide our community through uncertain times
•Share key healthcare impact learnings from those countries that are ahead in the COVID-19 curve
•Look at how we can, together, best support patients, healthcare professionals, life sciences and governments to reduce the impact of the virus

This April webinar will take place on Thursday 23rd April from 12.30 to 13.30 (BST) / 07:30 to 08:30 (EST).

You can listen to our March webinar here: https://pharmaphorum.com/r-d/the-potential-impact-of-coronavirus-covid-19-for-global-pharma-and-biotech-continuity/

Focus

During the April instalment, our expert panel will discuss:
•Assessing the pharmaceutical market impact of COVID-19
•The UK clinical trials on COVID-19: navigating uncharted waters
•Genomics: research in the time of COVID-19
•Knowledge sharing: the COVID-19 experience from a US perspective
•Getting clinical research back up and running post-coronavirus
•Adjustments to new medicine launch planning

This pharmaphorum webinar will take place on 8th April and comes as the COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus vaccine.

Thrown into even sharper relief than usual are the needs faced by all vaccine trials to balance study speed, data accuracy and patient experience.

Additionally, given the fear of exposure and city mandates for individuals to stay at home, traditional patient recruitment challenges are exacerbated for a coronavirus trial. Placebo groups are unlikely to be used and the virus affects a very broad and non-discriminate patient population.

So, what is technology’s role in supporting the faster evaluation of vaccines? The right data capture technology can provide some important ways to first speed up vaccines research and then gain quicker regulatory submissions, compared with traditional paper records.

However, with patients’ expectations , it’s important to provide an experience of suitable quality to those who give up their time to take part in a study.

The pharmaphorum webinar Vaccines trials in the era of COVID-19 – balancing study speed, accuracy and patient experience is being held in association with ERT.

It is currently scheduled to take place on 8th April from 16:00 to 17:00 (BST) /11:00 to 12:00 (EST) and will look at how to balance trial speed, data accuracy and patient experience during the race for a coronavirus vaccine.

Focus
Our expert panel will discuss:
• Trial evolution so far and the impact of coronavirus
• Specific challenges for trial sponsors working on a coronavirus vaccine
• The impact of COVID-19 on patient attendance for studies
• Patient experience in vaccines clinical trials
• How to use virtual trial solutions, and when they’re not appropriate
• Efficient capture of patient data and RWE in rapid deployment trials

Overview
Pharmaceutical and biotech companies around the globe are working with Governments to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges.

Healthcare systems are being put under significant pressure, at a time when many are already over-stretched, medical congresses are being cancelled and bans on non-essential travel and enforced home working are emerging. Meanwhile, at local country level, Italy has gone into a country-wide lockdown and in China measures to prevent the virus’ spread have seen API manufacturing plants go offline.

This pharmaphorum webinar, held in association with IQVIA, will take place on Wednesday 18th March from 12:30-13:30 GMT with expert speakers outline potential scenarios, considerations and decisions that pharma and biotech would wish to plan for.

Focus
This COVID-19 continuity planning webinar will look at:
•COVID-19's potential impact on global pharmaceutical market dynamics
•Ways to support supply chain management
•Maintaining open lines of communication with healthcare professionals
•The application of artificial intelligence to potentially predict COVID-19 spread and patient infection
•Learning from China

Overview
In today’s digital world it is increasingly hard for pharmaceutical companies to successfully differentiate new brands based on their target product profile alone.

Instead, the key factor now is often the quality of customer engagement, which more and more healthcare professionals (HCPs) appear to value.

It’s enabled by a multichannel marketing (MCM) approach, but traditional MCM strategies require a much higher level of content than pharma is used to producing and approving – the answer to this is a modular approach.

Such modular content allows pharma to meet HCPs’ information demands by leveraging content assets across multiple channels and in many different combinations, at the same time providing superior targeting and tracking.

This pharmaphorum webinar, held in association with Anthill, will take place on Tuesday 17 March from 13:00 to 14:00 (GMT)/14:00 to 15:00 (CET) and will look at how the use of modular content in pharma can ease some digital worries.

Focus
Our expert panel will discuss:

•The most common challenges in the digital content creation process
•Aligning content creation tactics with the multichannel marketing strategy
•How to activate your existing content to maximise existing resource for the greatest HCP reach
•Making the customer experience a key differentiator

Our Panel
•Morten Kruse Sørensen, Global Director Multichannel Excellence and Operations, Novo Nordisk
•Florent Edouard, SVP, Global Head of Commercial Excellence, Grünenthal Group
•Huw Jenkins, Director, DAM Strategy, Veeva
•Kasper Jerlang, Head of Global Digital Marketing and Engagement, LEO Pharma
•Tor Kristensen, CTO, Anthill Agency
•Dominic Tyer, Creative and Editorial Director, pharmaphorum [moderator]

Chronic diseases are the leading cause of death and disability worldwide and have a staggering impact on patients’ lives and the provision of healthcare around the world.

Tackling conditions such as diabetes, heart disease and stroke is of vital importance if patient outcomes are to be improved and healthcare costs lowered.

To achieve this, and in doing so address clinical inertia, a combination of innovative communication strategies and behavioural science can provoke small changes that produce a meaningful difference in health outcomes.

This pharmaphorum webinar, in association with Complete HealthVizion, will look at how to help chronic disease patients to live well for longer, by providing a clear understanding of healthcare professionals’ and patients’ behaviours and communication needs.

Focus

The webinar will take place on Thursday 6th February from 14:00-15:00 GMT/09:00-10:00 EST, when a world-class faculty representing a wide-range of disciplines, including social science, multichannel and medical affairs strategy, will discuss how behavioural change approaches can be used to avoid major health problems and the increasing costs associated with declining health.

They will consider drivers of decision making in chronic disease management and look at why issues such as ‘behavioural complacency’ prevent progress and consider the lack of short-term benefits associated with many disease management approaches.

All too often there is little urgency to act in patients at risk from chronic disease, despite a growing burden that increases their suffering and the time they spend in clinical practices with HCPs.

This webinar will help change that, by looking at:

•How to assess readiness to change among patients and HCPs
•What strategic approaches work best in this setting
•How to target the most important HCPs and convince them of the need for change
•How to measure the effectiveness of behavioural change tactics

Overview

Patients are more informed than ever about their conditions and what is available for them to improve their quality of life.

The healthcare sector is increasingly focused on understanding patient needs and engaging them in the clinical development and medical information process. Therefore, it is paramount to create patient-focused educational content using a range of communication channels and digital tools.

However, do we take any time to think like a patient and, by doing so, understand their evolving needs and how this will affect the development of clinical trials and other healthcare educational initiatives?

This pharmaphorum webinar, held in association with Plenum and mdgroup, takes place on Wednesday 5th February from 14:00-15:00 GMT and will look at the impact of patient involvement, from clinical programme design through to launch and post-launch activities.

Focus

• What should patient-led communication look like and who will provide it?
• How to best meet patients’ needs during clinical trials
• Which meeting formats and other channels are most relevant to reach the broadest and most appropriate audiences?
• What role will each stakeholder play in the future?

Register to find out more and be part of this exciting debate.